Assessment of B cell depletion in combination with IL-2/anti-IL-2 mAb complexes in experimental arthritis

被引：0
|
作者：
Olalekan, Susan [1 ]
Cao, Yanxia [1 ]
Finnegan, Alison [1 ]
机构：
[1] Rush Univ, Immunol, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF IMMUNOLOGY | 2014年 / 192卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
THER5P.824
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation
    Jin, Gui-Hua
    Hirano, Toshio
    Murakami, Masaaki
    INTERNATIONAL IMMUNOLOGY, 2008, 20 (06) : 783 - 789
  • [12] IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines
    Sobral, Miguel C.
    Cabizzosu, Laura
    Kang, Shawn J.
    Ruark, Kyle
    Najibi, Alex J.
    Lane, Ryan S.
    Vitner, Einat
    Ijaz, Hamza
    Dellacherie, Maxence O.
    Dacus, Mason T.
    Tringides, Christina M.
    de Lazaro, Irene
    Pittet, Mikael J.
    Mueller, Soeren
    Turley, Shannon J.
    Mooney, David J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (48)
  • [13] Immunocomplexes of IL-2 and anti-IL-2 mAb as novel promising tool for cancer immunotherapy or combined chemo/immunotherapy
    Kovár, Marek
    Tomala, Jakub
    Chmelová, Helena
    Strohalm, Jiri
    Etrych, Tomás
    Ulbrich, Karel
    Rihova, Blanka
    TUMOR BIOLOGY, 2007, 28 : 85 - 85
  • [14] Sinergistic Therapeutic Effect of IL-2/anti-IL-2 mAb Complexes and Polymer-bound Doxorubicin Leads to Significantly Prolonged Survival of Mice
    Tomala, Jakub
    Kovar, Marek
    Chmelova, Helena
    Strohalm, Jiri
    Ulbrych, Karel
    Rihova, Blanka
    TUMOR BIOLOGY, 2008, 29 : 59 - 59
  • [15] Expansion of CD4+CD25+ Regulatory T Cells Via IL-2/Anti-IL-2 mAb Complexes Suppresses Experimental Autoimmune Myasthenia Gravis
    Liu, Ruolan
    Zhou, Qinghua
    La Cava, Antonio
    Campagnolo, Denise
    Luc Van Kaer
    Shi, Fu-Dong
    NEUROLOGY, 2011, 76 (09) : A580 - A580
  • [16] Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease
    Boyman, Onur
    Surh, Charles D.
    Sprent, Jonathan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (12) : 1323 - 1331
  • [17] Therapeutic Administration of IL-2/Anti-IL-2 Monoclonal Antibody Complexes Enhances Healing After Experimental Myocardial Infarction in Mice
    Weirather, Johannes
    Hofmann, Ulrich
    Beyersdorf, Niklas
    Kerkau, Thomas
    Frantz, Stefan
    CIRCULATION, 2014, 130
  • [18] IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor α subunit CD25
    Letourneau, Sven
    van Leeuwen, Ester M. M.
    Krieg, Carsten
    Martin, Chris
    Pantaleo, Giuseppe
    Sprent, Jonathan
    Surh, Charles D.
    Boyman, Onur
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (05) : 2171 - 2176
  • [19] Complexes of IL-2 and anti-IL-2 mAb selectively stimulating CD25+T cells in combination with immune checkpoint inhibitors possess potent antitumor activity but the timing is crucial
    Kilic, Irfan Baki
    Weberova, Petra
    Behalova, Katerina
    Ptacek, Bohumil
    Sirova, Milada
    Mazhara, Vladyslav
    Kubesova, Katerina
    Rihova, Blanka
    Kovar, Marek
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 774 - 774
  • [20] In vivo accumulation of T cells in response to IL-2/anti-IL-2 mAb complexes is dependent in part on the TNF family ligand 4-1BBL
    Lin, Gloria H. Y.
    Stone, John C.
    Surh, Charles D.
    Watts, Tania H.
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (07): : 743 - 747
12345